TAC1 Antibody

說(shuō)明書

中文名稱：

TAC1兔多克隆抗體
貨號(hào)：

CSB-PA023062LA01HU
規(guī)格：

￥440
圖片：
Western Blot
Positive WB detected in: HepG2 whole cell lysate
All lanes: TAC1 antibody at 1:2000
Secondary
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 16, 14, 12 kDa
Observed band size: 16 kDa

IHC image of CSB-PA023062LA01HU diluted at 1:1500 and staining in paraffin-embedded human endometrial cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
其他：

產(chǎn)品詳情
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) TAC1 Polyclonal antibody
Uniprot No.：

P20366
基因名：

TAC1
別名：

C-terminal-flanking peptide antibody; Hs.2563 antibody; neurokinin 1 antibody; neurokinin 2 antibody; neurokinin A antibody; neurokinin alpha antibody; Neuromedin L antibody; neuropeptide gamma antibody; neuropeptide K antibody; NK2 antibody; NKA antibody; NKNA antibody; NPK antibody; PPT antibody; preprotachykinin antibody; protachykinin antibody; protachykinin-1 antibody; Substance K antibody; SubstanceP antibody; TAC1 antibody; TAC2 antibody; TAC2; formerly antibody; Tachykinin 1 antibody; tachykinin 2 antibody; tachykinin 2; formerly antibody; Tachykinin precursor 1 antibody; tachykinin; precursor 1 (substance K; substance P; neurokinin 1; neurokinin 2; neuromedin L; neurokinin alpha; neuropeptide K; neuropeptide gamma) antibody; Tachykinin1 antibody; TKN1_HUMAN antibody
宿主：

Rabbit
反應(yīng)種屬：

Human
免疫原：

Recombinant Human Protachykinin-1 protein (20-129AA)
免疫原種屬：

Homo sapiens (Human)

標(biāo)記方式：

Non-conjugated

本頁(yè)面中的產(chǎn)品，TAC1 Antibody (CSB-PA023062LA01HU)，的標(biāo)記方式是Non-conjugated。對(duì)于TAC1 Antibody，我們還提供其他標(biāo)記。見(jiàn)下表：

標(biāo)記方式	貨號(hào)	產(chǎn)品名稱	應(yīng)用
HRP	CSB-PA023062LB01HU	TAC1 Antibody, HRP conjugated	ELISA
FITC	CSB-PA023062LC01HU	TAC1 Antibody, FITC conjugated
Biotin	CSB-PA023062LD01HU	TAC1 Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA, WB, IHC

推薦稀釋比：

Application	Recommended Dilution
WB	1:1000-1:5000
IHC	1:1000-1:2000

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
Immunohistochemistry (IHC) Protocol
儲(chǔ)存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

功能：

Tachykinins are active peptides which excite neurons, evoke behavioral responses, are potent vasodilators and secretagogues, and contract (directly or indirectly) many smooth muscles.
基因功能參考文獻(xiàn)：
1. Preincubation of LAD2 cells with the natural flavonoid methoxyluteolin (1-100 mM) inhibits (P < 0.0001) secretion and gene expression of IL-1beta, procaspase-1, and pro-IL-1beta. Mast cell secretion of IL-1beta in response to SP and IL-33 reveals targets for the development of antiinflammatory therapies. PMID: 30232261
2. High TAC1 expression is associated with primary central nervous system lymphoma. PMID: 28521029
3. These findings reported here for the first time suggest an important role for a SP/NK1R system, either as genetic and/or epigenetic factor, in both the cytoplasm and nucleus functions of the adipose stem cells. PMID: 28500728
4. This study showed that ADMA, carbonyl groups, CAT and NKA can be useful markers of chronic stress in both males and females with depression, PTSD, and depression concurrent with PTSD. PMID: 28554099
5. Inhibition of SP through use of a neurokinin 1 (NK1) antagonist is highly beneficial following both traumatic brain injury (TBI) and ischaemic stroke in pre-clinical models. The role of CGRP is more unclear, especially with respect to TBI, with both elevations and reductions in CGRP levels reported following trauma PMID: 28817088
6. serum SP levels during the first week could be used as a biomarker of sepsis mortality. PMID: 28714876
7. elevated plasma SP level, up-regulated expression of SP and NK1R indicate that the SP/NK1R complex is important in the development of Atopic dermatitis. PMID: 28460633
8. High methylation of TAC1 is associated with head and neck cancer. PMID: 27027429
9. Data suggest that serum substance P concentrations at the day of oocyte retrieval after ovulation induction may be used to predict oocyte maturation during in vitro oocyte maturation to be followed by intracytoplasmic sperm injections and may be an indirect indicator for treatment outcome in women with infertility. PMID: 27908224
10. expressed in mural granulosa and cumulus cells PMID: 27146034
11. Expression substance P/neurokinin A/hemokinin-1 and their preferred neurokinin 1/neurokinin 2 receptors are dysregulated in uterine leiomyomata. PMID: 27456549
12. These results suggest that Substance P can retain the therapeutic effect of adipose-derived stem cells by elevating their proliferative and paracrine potential in ex vivo culture. PMID: 28192115
13. Data suggest that endogenous tachykinin ligands for neurokinin-1 receptor exhibit large variations in binding/activation kinetics; substance P exhibits fast association kinetics; neurokinin A exhibits slow association kinetics. PMID: 27501920
14. Mapping the co-localization of the circadian proteins PER2 and BMAL1 with enkephalin and substance P throughout the rat forebrain has been reported. PMID: 28423013
15. Circulating Neurokinin A >/= 50 ng/L is a strong indicator of poor prognosis when Neurokinin A remains above this concentration PMID: 26038607
16. Substance P enhances tissue factor release from granulocyte-macrophage colony-stimulating factor-dependent macrophages via the p22phox/beta-arrestin 2/Rho A signaling pathway. PMID: 26852662
17. Decrease of mGluR5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease PMID: 24969128
18. Report absence of full-length neurokinin-1 receptor protein expression by cutaneous T cells in mycosis fungoides and discuss substance P signaling. PMID: 25783846
19. findings suggest a proinflammatory role for SP in autoimmune inflammation PMID: 25690155
20. The spatial structures of human, mouse, and rat hemokinin-1 protein isoforms have been presented. PMID: 26349209
21. Substance P was significantly increased in hypertrophic scars compared with matched unburned skin. In the reticular dermis and papillary dermis, SP represented significant correlation with pain. PMID: 24908181
22. High TAC1 expression is associated with breast cancer. PMID: 25750171
23. An increased presence of Substance P in the trochanteric bursa may be related to the pain associated with greater trochanteric pain syndrome. PMID: 24563019
24. Substance P is upregulated in the serum of patients with chronic spontaneous urticaria PMID: 24844859
25. SP may influence the KP and NKB secretory output via additional autocrine/paracrine mechanisms or regulate GnRH neurosecretion directly. PMID: 23977290
26. we define a three-gene panel, CDO1, HOXA9, and TAC1, which we subsequently validate in two independent cohorts of primary NSCLC samples PMID: 24486589
27. The results showed that the expression of SP and CGRP was significantly enhanced in the neurogenic SMSCs in response to IL-1beta, IL-6 and TNF-alpha, and the effect was remarkably inhibited by HA. PMID: 25135735
28. The antimicrobial peptide substance P has activity against invasive bacteria and fungi. PMID: 12074933
29. TAC1 expression level was differentially altered in Crohn disease and ulcerative colitis patients. PMID: 23827863
30. study investigated the role of SP in promoting the development of brain tumors; an increase in the levels of SP was noted in brain tumors; results suggest that SP and its NK1 receptor may play a major role in the progression of certain types of brain tumors PMID: 24374326
31. SP induces higher levels of CD163 in monocytes and that high expression of CD163 is associated with increases HIV infection in macrophages. PMID: 24577568
32. Substance P may be protective acutely following ischemia-reperfusion, but damaging long-term in non-ischemic induced remodeling and heart failure. PMID: 24286592
33. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth. PMID: 24603459
34. Copper(II) complexes of neuropeptide gamma with point mutations (S8,16A) products of metal-catalyzed oxidation. PMID: 24084156
35. Data indicate that both nucleus pulposus (NP) and annulus fibrosus (AF) cells expressed Substance P (SP) at low levels. PMID: 23873242
36. Substance P does not play any important role in pruritus in hemodialysed and peritoneal dialyzed patients. PMID: 23995243
37. Serum methylation levels of TAC1, SEPT9, and EYA4 were significant discriminants between stage I colorectal cancer and healthy controls. PMID: 23862763
38. TRH, LH-RH and substance P are not affected in Alzheimer disease and Down's syndrome. PMID: 24010162
39. The results showed that SP is present in the gengival sulcus in elements undergoing orthodontic forces during treatment with Invisalign technique and not in the control teeth. PMID: 23737731
40. Our results suggest that Substance P plays an important role in the development of pancreatic cancer metastasis and PNI, and blocking the SP/NK-1R signaling system is a novel strategy for the treatment of pancreatic cancer. PMID: 23345604
41. Data indicate that circulating substance P (SP) and TGF-beta1 levels are increased in patients with myelofibrosis. PMID: 22906243
42. CpG hypermethylation is a likely mechanism of TAC1 and TACR1 gene inactivation, supporting the hypothesis that TAC1 and TACR1 play a role in the tumorigenesis of HNSCC and that this hypermethylation may serve as an important biomarker. PMID: 23420374
43. SP stimulates complement C3 secretion in adipocytes, and expression of NK1R in human omental adipose tissue correlates with plasma complement C3. PMID: 23257919
44. Elevated substance P levels might be regarded as an important contributor of sulfur mustard-induced chronic pruritus and a potential target for reducing the symptoms PMID: 22681041
45. Expression of esophageal epithelial CGRP and substance P is increased, and correlates negatively with perception thresholds in non-erosive reflux disease. PMID: 22961239
46. This study aims to explore the associations of polymorphisms in tachykinin, precursor 1 (TAC1), tachykinin receptor 1 (TACR1), and tachykinin receptor 2 (TACR2) genes and their interactions with the risk of colorectal cancer among Chinese population. PMID: 22733436
47. This study indicates that SP, mediated via NK-1 R, increases collagen remodeling and leads to increased MMP3 mRNA and protein expression that is further enhanced by cyclic mechanical loading. PMID: 22836729
48. These data suggest a direct relationship between central nervous system substance P containing neural circuits and aggression in human subjects PMID: 22449753
49. Tissue and serum levels of substance P were increased in chronic pancreatitis, while neprilysin levels remained unaltered. PMID: 22572771
50. The unique co-existence of SP and phospho-NMDAR1 in tendinopathy presumably reflects a tissue proliferative and nociceptive role. PMID: 22354721
顯示更多

收起更多
亞細(xì)胞定位：

Secreted.
蛋白家族：

Tachykinin family
數(shù)據(jù)庫(kù)鏈接：

HGNC: 11517

OMIM: 162320

KEGG: hsa:6863

STRING: 9606.ENSP00000321106

UniGene: Hs.2563

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human
WDR5 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human